AusPAR: Adalimumab

Australian Public Assessment Report

AusPAR

AusPAR: Adalimumab [PDF, 1009.64 KB]

AusPAR: Adalimumab [Word, 1.5 MB]

Attachment: Product Information: Adalimumab [PDF, 667.68 KB]

Attachment: Product Information: Adalimumab [Word, 365.04 KB]

Device/Product Name

Hadlima

Active ingredients

Adalimumab

AusPAR Date

13 March 2019

Published

16 May 2019

Submission Number

PM-2016-03547-1-3

Submission Type

New biosimilar medicine

Decision

Approved